ArticleFrontiers in oncology2022

Case report: Changes in serum bevacizumab concentration in a hemodialysis patient with unresectable colorectal cancer treated with FOLFIRI plus bevacizumab.

Toshimitsu Tanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.